1. Home
  2. RGCO vs LENZ Comparison

RGCO vs LENZ Comparison

Compare RGCO & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RGC Resources Inc.

RGCO

RGC Resources Inc.

HOLD

Current Price

$23.62

Market Cap

233.9M

Sector

Utilities

ML Signal

HOLD

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

HOLD

Current Price

$5.82

Market Cap

198.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGCO
LENZ
Founded
1912
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medicinal Chemicals and Botanical Products
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.9M
198.8M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
RGCO
LENZ
Price
$23.62
$5.82
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$22.70
$44.00
AVG Volume (30 Days)
7.3K
614.9K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
3.93%
N/A
EPS Growth
11.21
N/A
EPS
1.31
N/A
Revenue
$95,334,212.00
$19,088,000.00
Revenue This Year
$11.06
$50.42
Revenue Next Year
$2.89
$197.16
P/E Ratio
$18.81
N/A
Revenue Growth
12.63
N/A
52 Week Low
$19.68
$5.23
52 Week High
$26.63
$50.19

Technical Indicators

Market Signals
Indicator
RGCO
LENZ
Relative Strength Index (RSI) 55.96 31.78
Support Level $20.80 N/A
Resistance Level N/A $10.42
Average True Range (ATR) 0.81 0.44
MACD 0.09 -0.03
Stochastic Oscillator 47.52 26.82

Price Performance

Historical Comparison
RGCO
LENZ

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

Share on Social Networks: